Chubb Corp’s GSK GSK Stock Holding History

Chubb Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	$22.2M	Hold	440,000	–	–	1.79%	25
2015 Q3	$21.1M	Hold	440,000	–	–	1.22%	38
2015 Q2	$22.9M	Buy	440,000 +80,000	+22%	+$4.5M	1.19%	30
2015 Q1	$20.8M	Buy	360,000 +215,200	+149%	+$12.3M	1.08%	43
2014 Q4	$7.74M	Hold	144,800	–	–	0.4%	88
2014 Q3	$8.32M	Hold	144,800	–	–	0.45%	88
2014 Q2	$9.68M	Hold	144,800	–	–	0.5%	89
2014 Q1	$9.67M	Hold	144,800	–	–	0.53%	89
2013 Q4	$9.66M	Hold	144,800	–	–	0.54%	89
2013 Q3	$9.08M	Hold	144,800	–	–	0.5%	88
2013 Q2	$9.04M	Buy	+144,800	New	+$9.19M	0.49%	89

Other funds holding GSK

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Chubb Corp's GSK Position: Q4 2015 in Review

Chubb Corp held its GSK (GSK) position steady in Q4 2015 at 440,000 shares worth $22.2M. The position accounts for 1.79% of the portfolio, ranked #25.

Chubb Corp first reported a position in GSK in Q2 2013 and has held it in 11 quarters since. The position peaked at $22.9M in Q2 2015. 719 funds tracked by Wall St. Rank hold GSK as of Q4 2015.

Chubb Corp held 440,000 shares of GSK worth $22.2M as of Q4 2015.
Chubb Corp left its GSK share count unchanged in Q4 2015.
GSK made up 1.79% of Chubb Corp's portfolio in Q4 2015, its #25 holding.
Chubb Corp first reported a position in GSK in Q2 2013 and has held it in 11 quarters since.
Chubb Corp's GSK position peaked at $22.9M in Q2 2015.
719 funds tracked by Wall St. Rank held GSK as of Q4 2015.

Based on Chubb Corp's 13F filing for Q4 2015, filed 11 Feb 2016.